Organon & Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68622V1061
USD
13.40
0.01 (0.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,460.00
1,507.00
1,602.00
1,594.00
1,513.00
1,592.00
1,582.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,460.00
1,507.00
1,602.00
1,594.00
1,513.00
1,592.00
1,582.00
Raw Material Cost
670.00
748.00
745.00
720.00
672.00
696.00
659.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
113.00
123.00
131.00
132.00
128.00
136.00
126.00
Selling and Distribution Expenses
424.00
433.00
415.00
453.00
420.00
462.00
422.00
Other Expenses
-2.00
-3.20
-4.70
-3.70
-3.20
-0.60
-1.50
Total Expenditure (Excl Depreciation)
1,187.00
1,272.00
1,244.00
1,268.00
1,188.00
1,288.00
1,192.00
Operating Profit (PBDIT) excl Other Income
273
235
358
326
325
304
390
Other Income
84.00
-5.00
20.00
31.00
1.00
-54.00
-6.00
Operating Profit (PBDIT)
443.00
319.00
470.00
446.00
410.00
326.00
453.00
Interest
113.00
123.00
131.00
132.00
128.00
136.00
126.00
Exceptional Items
-31.00
-255.00
-4.00
4.00
-97.00
15.00
-51.00
Gross Profit (PBDT)
790.00
759.00
857.00
874.00
841.00
896.00
923.00
Depreciation
86.00
89.00
92.00
89.00
84.00
76.00
69.00
Profit Before Tax
213.00
-148.00
243.00
229.00
101.00
129.00
207.00
Tax
67.00
57.00
83.00
84.00
14.00
20.00
-152.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
146.00
-205.00
160.00
145.00
87.00
109.00
359.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
146.00
-205.00
160.00
145.00
87.00
109.00
359.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
146.00
-205.00
160.00
145.00
87.00
109.00
359.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
903.00
752.00
906.00
733.00
542.00
472.00
493.00
Earnings per share (EPS)
0.56
-0.79
0.61
0.56
0.33
0.42
1.38
Diluted Earnings per share
0.56
-0.79
0.61
0.56
0.33
0.42
1.38
Operating Profit Margin (Excl OI)
18.7%
15.59%
22.35%
20.45%
21.48%
19.1%
24.65%
Gross Profit Margin
20.48%
-3.92%
20.91%
19.95%
12.23%
12.88%
17.45%
PAT Margin
10.0%
-13.6%
9.99%
9.1%
5.75%
6.85%
22.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -3.12% vs -5.93% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 171.22% vs -228.12% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 10.80% vs -28.00% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -8.13% vs -6.11% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Organon & Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,460.00
268.30
1,191.70
444.17%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,460.00
268.30
1,191.70
444.17%
Raw Material Cost
670.00
40.84
629.16
1,540.55%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
113.00
10.32
102.68
994.96%
Selling and Distribution Expenses
424.00
124.03
299.97
241.85%
Other Expenses
-2.00
6.66
-8.66
-130.03%
Total Expenditure (Excl Depreciation)
1,187.00
241.83
945.17
390.84%
Operating Profit (PBDIT) excl Other Income
273.00
26.47
246.53
931.36%
Other Income
84.00
3.00
81.00
2,700.00%
Operating Profit (PBDIT)
443.00
29.76
413.24
1,388.58%
Interest
113.00
10.32
102.68
994.96%
Exceptional Items
-31.00
0.00
-31.00
Gross Profit (PBDT)
790.00
227.46
562.54
247.31%
Depreciation
86.00
0.29
85.71
29,555.17%
Profit Before Tax
213.00
19.15
193.85
1,012.27%
Tax
67.00
0.50
66.50
13,300.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
146.00
18.66
127.34
682.42%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
146.00
18.66
127.34
682.42%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
146.00
18.66
127.34
682.42%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
903.00
414.92
488.08
117.63%
Earnings per share (EPS)
0.56
0.14
0.42
300.00%
Diluted Earnings per share
0.56
0.14
0.42
300.00%
Operating Profit Margin (Excl OI)
18.70%
9.86%
0.00
8.84%
Gross Profit Margin
20.48%
7.25%
0.00
13.23%
PAT Margin
10.00%
6.95%
0.00
3.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 146.00 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -3.12% vs -5.93% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -3.50% vs -6.72% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 14.60 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 171.22% vs -228.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 67.82% vs -56.72% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 10.80% vs -28.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -12.22% vs -14.61% in Mar 2025

Quarterly - Interest
Interest 11.30 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.13% vs -6.11% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -11.72% vs -2.29% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.70%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025